Breaking News
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. Upgrade now
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Pharma Mar SAU (PHMMF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
132.650 +2.400    +1.84%
24/02 - Closed. Currency in USD ( Disclaimer )
After Hours
132.375
-0.275
-0.207%
21:51:02 - Delayed Data
Type:  Equity
Market:  United States
ISIN:  ES0169501022 
  • Volume: 458
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 131.950 - 132.650
Pharma Mar 132.650 +2.400 +1.84%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close130.25
Day's Range131.95 - 132.65
Revenue297.01M
Open131.95
52 wk Range33.6 - 158.75
EPSN/A
Volume458
Market Cap2.49B
Dividend (Yield)0.54 (0.57%)
Average Volume (3m)1,883
P/E RatioN/A
BetaN/A
1-Year Change160.1%
Shares OutstandingN/A
Next Earnings DateFeb 25, 2021
What is your sentiment on Pharma Mar SAU?
or
Market is currently closed. Voting is open during market hours.

Pharma Mar SAU News


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Sell Sell Neutral Buy Buy
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Buy
Summary Strong Sell Strong Sell Sell Neutral Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Black Crows 1W Current
Completed Patterns
Three Outside Down 1M 2 Dec 20
Engulfing Bearish 1M 3 Nov 20
Evening Doji Star 1M 3 Nov 20

Pharma Mar SAU Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Real-time derived 111.600 - - - +1.92% EUR 11:30:12  
  Madrid 111.300 111.200 111.300 52,921 +2.02% EUR 11:15:39  
  OTC Markets 132.650 0.000 0.000 458 +1.84% USD 24/02  
  London 109.60 111.00 112.00 22 +2.91% EUR 09:02:25  
  Frankfurt 109.000 111.000 112.000 0 +1.87% EUR 08:18:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Guaranty Trust Bank 31.00 31.05 31.00 -0.05 -0.16% 10.15M 11:00:00  
  Dangote Cement 209.00 209.00 209.00 -11.00 -5.00% 11.17K 10:54:00  
  UBA 8.45 8.55 8.45 -0.05 -0.58% 6.54M 11:00:00  
  Zenith Bank 25.95 26.20 25.95 -0.35 -1.33% 6.75M 11:00:00  
  Berger Paints 6.55 6.55 6.55 -0.70 -9.66% 0.00K 10:20:00  
  Cutix 2.170 2.170 2.170 -0.080 -3.56% 2.66K 10:57:00  
  Jaiz Bank 0.69 0.69 0.63 +0.03 +4.55% 450.66K 10:58:00  
  Oando Plc 3.59 3.70 3.43 +0.18 +5.28% 6.59M 11:00:00  
  Honyflour 1.200 1.200 1.200 -0.050 -4.00% 163.66K 10:57:00  
  Ikeja 1.270 1.270 1.270 0.000 0.00% 0 24/02  

Pharma Mar SAU Company Profile

IndustryBusiness Services
SectorServices
Employees

445

Equity Type

ORD

Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PHMR Comments

Write your thoughts about Pharma Mar SAU
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email